MMP9 and colorectal carcinoma: In CRC cells, other studies have shown that C2Cnt is able to induce a reduction in cell viability, affect the wound healing capacity, and reduce matrix metalloproteinase-9 (MMP-9) and VEGF expression levels, suggesting the ability of C2Cnt to counteract the adhesion, migration, and invasion of HT-29 cells [28].